Fertility Germline Testing denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for fertility germline testing are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Applies Quantity Limits to Germline Testing — and How to Appeal

Cigna's coverage policies for germline genetic testing often restrict the number of tests, panels, or CPT units covered within a defined period. A quantity-limit denial is issued when the billed test quantity or the number of genes in a panel exceeds what Cigna's policy recognizes as appropriate for a single clinical episode. In a fertility or reproductive medicine context, this can affect multi-gene carrier screening panels, expanded preimplantation genetic testing, or sequential testing across a treatment cycle.

## Why This Denial Is Appealable

Quantity-limit denials can be overturned when the clinical record demonstrates that the additional quantity was medically necessary — for example, when the treating clinician needed a broader panel because family history or prior results indicated additional genes of concern, or when repeat testing was required due to specimen adequacy issues outside the patient's control. The key is establishing a documented clinical rationale for each unit of testing beyond the standard limit.

## Your Federal Appeal Rights

• Internal appeal: ERISA §503 (employer plans) or applicable state insurance law entitles you to a full-and-fair internal review. File within the deadline on your EOB — typically 180 days.
• External review: Under ACA §2719, once internal remedies are exhausted, you may request binding independent external review. The full window is approximately four months from denial. Expedited review (72-hour decision) is available when medically urgent.

## Concrete Appeal Steps and Timeline

1. Identify the specific quantity Cigna allowed versus what was billed — the EOB should specify the covered units and the reason for the overage denial. 2. Request Cigna's written policy for the test codes billed, including the quantity limit and any clinical exception criteria. 3. Coordinate with the ordering provider to document the clinical rationale for each test unit or panel component that exceeded the limit. 4. File internal appeal within the EOB deadline. 5. Escalate to external review if the internal appeal is upheld.

## Documentation to Gather

• Ordering physician letter: Explains why the number of tests or the panel breadth was clinically required, citing the specific clinical facts (family history findings, prior test results, specimen issues) that drove the decision.
• Diagnosis and history records: Chart notes documenting the evolving clinical picture that necessitated testing beyond a standard panel.
• Laboratory report and order: Confirms exactly what was ordered and why each component was included.
• Specimen adequacy records: If retesting was required due to a failed specimen, laboratory documentation of the failure is essential.
• Applicable guideline reference: The relevant professional society guideline body (e.g., ACOG, NSGC, ASRM) may support broader testing in specific clinical scenarios — cite the organization, not specific numbers.

## Criteria-Mapping Structure

In your appeal letter, address each unit of denied testing separately. For each: (1) state the quantity Cigna's policy allows, (2) state what was billed, and (3) provide the specific chart fact that justifies the excess quantity. A per-unit justification is far more persuasive than a single narrative explanation and makes it difficult for the reviewer to issue a blanket uphold.